Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
3.
Med Glas (Zenica) ; 18(1): 226-231, 2021 02 01.
Article in English | MEDLINE | ID: mdl-33078916

ABSTRACT

Aim To determine the effect of the load on the meniscus in relation to a different angle, and to present the impact of force on eventual injury of menisci. Methods Research included 200 males with average height of 178.5 cm, mass 83.5 kg, and average age of 22 years. The simulation of treadmill that was used in the evaluation of ischemic heart disease was made. Effects on the knee were evaluated by measuring at different inclinations (5°70', 6°80', 7°90', 9°10', 10°20', 11°30' and 12°40'). Results With increasing ascent of treadmill the load on the meniscus also increased. Each increase in ascent after 22% (which corresponded to the angle of 12°40' and seventh degree of load according to the Bruce protocol) at given anthropological values was an etiological factor for meniscus injury. Conclusion The seventh degree of load according to the Bruce protocol can lead to the meniscus injury.


Subject(s)
Knee Joint , Menisci, Tibial , Adult , Biomechanical Phenomena , Humans , Male , Young Adult
4.
Med Arch ; 74(2): 146-150, 2020 Apr.
Article in English | MEDLINE | ID: mdl-32577059

ABSTRACT

INTRODUCTION: Non-muscle-invasive bladder cancer (NMIBC) is usually effectively treated with transurethral resection (TUR), most often followed by intravesical instillation of bacillus Calmette-Guérin (BCG) or intravesical chemotherapy. Although the precise mechanism of BCG immunotherapy is still unclear, a local immune response is presumed. However, a number of severe side effects and complications are related to intravesical immunotherapy. AIM: Aim of this report is to present rare case of the renal granulomatous disease in a patient previously treated with intravesical instillation of BCG immunotherapy, following TURBT. In addition, we performed review of previously reported cases of renal granulomas following intravesical BCG immunotherapy. CASE REPORT: A 79-year-old man was presented to Urology Clinic due to clinically verified tumor of the urinary bladder. After transurethral resection of bladder tumor, histopathological analysis revealed the diagnosis of papillary urothelial high-grade pT1 carcinoma. Intravesical BCG immunotherapy was initiated, according to protocol currently used in our institution. Upon completion of therapy with BCG, we re-examined the patient and, using ultrasound, found a change in the right kidney, resembling moth bites not seen on CT scan before TURBT. Additionally, CT-guided core-needle biopsy of the affected kidney was performed, and the specimen was sent for histopathological analysis, which revealed chronic necrotizing granulomatous inflammation. Antituberculotic therapy was initiated for 6 months. Upon completion of antituberculotic therapy, control CT-scan was performed at follow-up, indicating regression of changes on the right kidney. CONCLUSION: This case report emphasizes the importance of consistent implementation of follow-up protocol and the identification of lesions during the asymptomatic period and enables the proper treatment of the disease. To reduce the incidence of adverse effects of BCG treatment for bladder tumors, an individualized approach is needed.


Subject(s)
BCG Vaccine/adverse effects , Carcinoma, Transitional Cell/therapy , Cystoscopy , Immunologic Factors/adverse effects , Tuberculosis, Renal/etiology , Urinary Bladder Neoplasms/therapy , Administration, Intravesical , Aged , Antitubercular Agents/therapeutic use , Biopsy, Large-Core Needle , Humans , Male , Tomography, X-Ray Computed , Tuberculosis, Renal/diagnostic imaging , Tuberculosis, Renal/drug therapy , Tuberculosis, Renal/pathology
5.
Med Princ Pract ; 28(5): 485-489, 2019.
Article in English | MEDLINE | ID: mdl-30897574

ABSTRACT

OBJECTIVE: We present a 17-year-old boy with an incidentally diagnosed left adrenal ganglioneuroma during the diagnostic workup of alopecia areata. CLINICAL PRESENTATION AND INTERVENTION: Laboratory investigations revealed vitamin D deficiency. Laparoscopic adrenalectomy was performed and ganglioneuroma was confirmed histologically. At follow-up, the vitamin D supplements improved the vitamin D levels followed by a gradual regression of alopecia areata. However, it recurred 18 months later despite the normal levels of serum vitamin D and no tumor recurrence. CONCLUSION: Further studies should reveal the relationship between alopecia areata and ganglioneuroma as well as the role of vitamin D in alopecia areata.


Subject(s)
Adrenal Gland Neoplasms/surgery , Ganglioneuroma/surgery , Adolescent , Adrenal Gland Neoplasms/diagnostic imaging , Alopecia Areata/complications , Ganglioneuroma/diagnostic imaging , Humans , Laparoscopy , Male , Treatment Outcome , Vitamin D Deficiency/complications
6.
Medicine (Baltimore) ; 98(4): e14232, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30681605

ABSTRACT

RATIONALE: Hydrocele of the canal of Nuck is a rare developmental disorder and represents of a homolog of hydrocele of spermatic cord in males. Hydrocele of the canal of Nuck is a very rare cause of inguinal swelling in female infants and children. It results from the failure of obliteration of the distal portion of evaginated parietal peritoneum within the inguinal canal, which forms a sac containing fluid. PATIENT CONCERNS: We describe a case of hydrocele of the canal of Nuck in an 11-month-old girl with a past medical history of duodenal atresia and Arnold-Chiari malformation. DIAGNOSIS: Physical examination and ultrasound revealed a soft, cystic, noncompressible, and non-fluctuant labial mass measuring approximately 5 cm. INTERVENTIONS: The patient underwent surgical exploration through a right skin crease incision. The cystic lesion was histologically confirmed to be a non-communicated hydrocele of canal of Nuck. OUTCOMES: The child is doing well at 1-year follow-up with no swelling or recurrence on the operated side. LESSONS: Hydrocele of the canal of Nuck is a rare developmental disorder but should be considered in a differential diagnosis in young girls with an inguino-labial swelling.


Subject(s)
Arnold-Chiari Malformation/complications , Cysts/congenital , Duodenal Obstruction/complications , Genital Diseases, Female/congenital , Intestinal Atresia/complications , Peritoneal Diseases/congenital , Cysts/pathology , Female , Genital Diseases, Female/pathology , Humans , Infant , Inguinal Canal , Peritoneal Diseases/pathology
7.
Int J Gynecol Pathol ; 36(1): 95-100, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27391272

ABSTRACT

Cervical carcinoma is the second most common female malignancy worldwide. It usually spreads by direct local extension or the lymphatic vessels. Hematogenous dissemination with distant skeletal muscle metastases is a rare phenomenon. We report here 2 patients whose recurrent squamous cell carcinomas of the cervix presented with symptomatic skeletal muscle metastases affecting the muscles of the thoracic wall and forearm, respectively. We also discuss the differential diagnosis and comprehensively review the previously published literature on this rare presentation of cervical carcinoma.


Subject(s)
Carcinoma, Squamous Cell/pathology , Muscle Neoplasms/secondary , Uterine Cervical Neoplasms/pathology , Adult , Carcinoma, Squamous Cell/diagnostic imaging , Cervix Uteri/pathology , Diagnosis, Differential , Female , Humans , Muscle Neoplasms/diagnostic imaging , Muscle Neoplasms/pathology , Muscle, Skeletal/pathology , Neoplasm Recurrence, Local , Uterine Cervical Neoplasms/diagnostic imaging
8.
Med Arch ; 70(5): 342-347, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27994293

ABSTRACT

INTRODUCTION: Non Hodgkin lymphoma-Diffuse large B cell lymphoma (DLBC) is composed of more varieties of one disease. Analysis and understanding of a wide range of characteristics of the disease, which include: clinical, immunohistochemical, cytogenetic and molecular characteristics may improve treatment results. AIM: achieving the estimated three-year survival and influence of IRF/MUM1 expression to three-year survival. MATERIAL AND METHODS: A study was retrospective-prospective, patients were followed for seven years a period of dine. The study included 60 patients de novo DLBCL. Age was 18-72 years old, the average age 45 years, male 31 (51,7%) and female 29 (48.3%). Median follow-up was 47 months (3-91 months). To determine differentiation immunophenotype antibodies those were used anti-CD20, anti-CD10, anti-Bcl-6, IRF-4/MUM1, CD 138. RESULTS: Included the GCB type was 65%. Impact prognostic index IPI>2 GBC vs non GBC p=0,038 X2. Statistically significant difference was confirmed compared to the IPI> 2 to 3 year OS p<0,0005 X2. Significantly longer three-year survival was provided in the group GCB 36 (92,3%) vs. non GCB 8 (38,1%) p=0,003 X2. Clinical and immunohistochemical factors showed a significant impact to three-year survival by univariate: LDH p=0,005, MUM1 p=0,003, while CD10 p=0,069 was confirmed on the level of borderline impact. Using multivariate analysis, expression MUM1 has the greatest impact p<0.0005 OR=0.083 (95% CI 0.23-0.303) on the disease outcome - three-year survival. CONCLUSION: expression MUM1 >25% has the greatest impact on the disease outcome - three-year survival.


Subject(s)
Interferon Regulatory Factors/metabolism , Lymphoma, Large B-Cell, Diffuse/metabolism , Lymphoma, Large B-Cell, Diffuse/mortality , Adolescent , Adult , Aged , Female , Humans , Immunotherapy , Lymphoma, Large B-Cell, Diffuse/drug therapy , Male , Middle Aged , Prospective Studies , Retrospective Studies , Survival Rate , Treatment Outcome , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL